NCT07674719尚未招募不适用
The Effect of Intraoperative Remimazolam Administration on the Incidence of Postoperative Acute Kidney Injury After Hepatobiliary and Pancreatic Surgery : a Prospective Randomized Controlled Trial
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 78
- 试验地点
- 1
- 主要终点
- Acute kidney injury
研究概览
简要总结
We hypothesized that in patients undergoing elective hepatobiliary-pancreatic surgery, the group in which anesthesia is induced and maintained with remimazolam during surgery would maintain hemodynamic stability and reduce the incidence of postoperative acute kidney injury compared to propofol. The purpose is to provide practical evidence for perioperative management differentiated from other surgeries for hepatobiliary-pancreatic surgery patients for whom intraoperative fluid therapy is restricted.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 85 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ages 19 or older and under 85
- •Patients scheduled to undergo elective hepatopancreatic surgery under general anesthesia
- •American Society of Anesthesiologists (ASA) physical grade 1-3
- •Those who voluntarily consented to a written informed consent form prior to participation in the study
排除标准
- •Patients with hypersensitivity to other benzodiazepine drugs, including remimazolam, and to the components of this drug (e.g., patients with severe hypersensitivity to dextran 40)
- •Patients with hypersensitivity to propofol
- •Patients with underlying conditions: liver, neurological disorders, or acute narrow-angle glaucoma
- •Patients with severe or acute respiratory failure
- •Patients in shock or a coma
- •Patients taking TCA antidepressants
- •Patients with preoperative chronic kidney disease
研究组 & 干预措施
Remimazolam
Experimental
干预措施: Remimazolam (Byfavo) (Drug)
Propofol
Active Comparator
干预措施: propofol (Drug)
结局指标
主要结局
Acute kidney injury
时间窗: preop, postop day 0, 1, 3, 5
serum creatinine
次要结局
未报告次要终点
研究者
Park InSun
Assistant Professor
Seoul National University Bundang Hospital
研究点 (1)
Loading locations...
相似试验
尚未招募
1 期
苯磺酸瑞马唑仑在上消化道内镜手术麻醉中的临床研究ChiCTR2200062535104
尚未招募
不适用
Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic GastrectomyNCT07351474The First Affiliated Hospital with Nanjing Medical University170
招募中
不适用
Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary SurgeriesNCT07263061Institute of Liver and Biliary Sciences, India1,000
Unknown
不适用
瑞马唑仑对高危患者全身麻醉后恶心呕吐发生率的影响: 一项前瞻性随机对照研究ChiCTR2100043060自筹经费552
Unknown
不适用
瑞马唑仑对肝脏部分切除术患者术后肝功能的影响ChiCTR2600116211自筹105
